The Case Builds: Novel SCI peptide also shows promise for heart attack and dangerous arrhythmias

Beth A. Habecker

Beth A. Habecker

Case Western Reserve’s chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.

Case Western Reserve neurosciences professor Jerry Silver long has believed that lessons learned over decades from spinal cord research could someday apply to other areas of the body. He got the chance to test his theory when a colleague from another campus realized that his new compound—intracellular sigma peptide (ISP)—could address a critical cardiac issue.

The results of the project, led by Oregon Health & Sciences University (OHSU) researcher Beth A. Habecker, exceeded even Silver’s greatest hopes: 100 percent success in animal models. Details can be found in the Feb. 2 edition of Nature Communication.

Full Article Link Here: Novel peptide shows promise in penetrating heart attack scar tissue to regenerate cardiac nerves and avert dangerous arrhythmias

This entry was posted in Chronic Spinal Cord Injury Research, Regenerative Medicine and tagged , , , . Bookmark the permalink.

One Response to The Case Builds: Novel SCI peptide also shows promise for heart attack and dangerous arrhythmias

Comments are closed.